Tag: Biocon Limited
Biocon launches formulation for diabetes and obesity
Biocon Limited, a global biopharmaceutical company, has announced the launch of its GLP-1 peptide, Liraglutide, for diabetes and obesity, in the United Kingdom (U.K.)....